A Study to Evaluate if Hydroxychloroquine Can Prevent COVID-19 Infection in Healthcare Workers (HERO-HCQ Trial)

Official Title: Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial)

Purpose:

HERO-HCQ is a randomized clinical trial of approximately 2,000 HERO Registry participants. This trial will test whether hydroxychloroquine (HCQ, brand name Plaquenil®) can prevent COVID-19 infection in healthcare workers(heroesresearch.org)

Eligibility criteria:

- You must be a healthcare worker over 18 years of age
- You must currently work in a healthcare setting which puts you at risk for COVID-19 infection

Contact Information


Jennifer Frey

frey.62@osu.edu

Back